Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Nov 10, 2023 8:14am

144 Views

Post# 35727862

Could be a close call at home plate....

Split it down the middle at $8 million annualized or $2 M per quarter vs last earnings -$3.2 M EBITDA.

Why I say, AVCN new agreement "could" be a wild card?

Below from last quarters performance.

Successful integration of VIVO, including executing a restructuring and cost savings program that will save approximately $7M on an annualized basis as we progress towards our previously communicated synergy target of $7 - $9M . (2)(3)(4)(5)
Adjusted EBITDA (1) of negative $3.2M